Rani Therapeutics Holdings RANI
NASDAQ RANI
$0.88 +0.03 (+3.41%)
At close: Aug 21, 2026 · 4:00 PM EDT

Rani Therapeutics Holdings (RANI) Long-Term Debt Issuances (2020 - 2022)

Rani Therapeutics Holdings (RANI) posted quarterly Long-Term Debt Issuances of $14.9 million for Q4 2022, up 1.58% quarter-over-quarter from $14.7 million in Q3 2022.

Rani Therapeutics Holdings (RANI) Long-Term Debt Issuances (2020 - 2022) Analysis & Trends

Rani Therapeutics Holdings' Long-Term Debt Issuances history runs 3 years deep, the most recent figure standing at $14.9 million for Q4 2022.

  • In Q4 2022, Long-Term Debt Issuances changed N/A year-over-year to $14.9 million; the TTM figure through Dec 2023 stood at $29.6 million (changed 0.0% YoY), while the FY2022 annual figure was $29.6 million, up 1619.42% from the prior year.
  • Long-Term Debt Issuances for Q4 2022 stood at $14.9 million, up from $14.7 million in the prior quarter.
  • The five-year high for Long-Term Debt Issuances was $14.9 million in Q4 2022, with the low at -$1.5 million in Q4 2020.
  • The 3-year median for Long-Term Debt Issuances is $2.8 million (2020), against an average of $6.5 million.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Debt Issuances (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn -
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn -
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 Rani Therapeutics Holdings 163.98 Mn 163.98 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2022 14.90 Mn
Dec 31, 2022 14.90 Mn
Sep 30, 2022 14.67 Mn
Sep 30, 2022 14.67 Mn
Mar 31, 2021 1.72 Mn
Mar 31, 2021 1.72 Mn
Dec 31, 2020 -1.53 Mn
Dec 31, 2020 -1.53 Mn
Sep 30, 2020 2.78 Mn
Sep 30, 2020 2.78 Mn